来自专业的译者、企业、网页和免费的翻译库。
genentech inc.
genentech, inc.
最后更新: 2017-04-26
使用频率: 1
质量:
regeneron pharmaceuticals, inc.
regeneron pharmaceuticals inc.
最后更新: 2017-04-26
使用频率: 1
质量:
dysacusis (inc tinnitus)*
hljóðkvöl (þ.m.t. eyrnasuð)
最后更新: 2017-04-26
使用频率: 1
质量:
(c) 2001 red hat, inc.
(c) 2001 red hat, inc.
最后更新: 2011-10-23
使用频率: 1
质量:
colitis (inc clostridium difficile)*
ristilbólga (þ.m.t. vegna clostridium difficile)
最后更新: 2017-04-26
使用频率: 1
质量:
cardiovascular disorder (inc cardiogenic shock)
hjarta- og æðasjúkdómur (þ.m.t. hjartalost)
最后更新: 2017-04-26
使用频率: 1
质量:
the name of the organization you work for. ex: knode, inc.
nafn stofnunarinnar sem þú vinnur fyrir. t. d.: knode, inc.
最后更新: 2011-10-23
使用频率: 1
质量:
hepatotoxicity (inc liver disorder), hepatitis*,
eiturverkun á lifur (þ.m.t. röskun á lifrarstarfsemi), lifrarbólga*, gallteppa
最后更新: 2017-04-26
使用频率: 1
质量:
name and address of the manufacturer of the biological active substance: zoetis inc.
heiti og heimilisfang framleiðanda líffræðilegs virks efnis: zoetis inc.
最后更新: 2017-04-26
使用频率: 2
质量:
(c) 2001 red hat, inc. & luís pedro coelho
(c) 2001 red hat, inc. & luís pedro coelho
最后更新: 2011-10-23
使用频率: 1
质量:
警告:包含不可见的HTML格式
hepatotoxicity (inc liver disorder), hepatitis*, cholestasis
eiturverkun á lifur (þ.m.t. röskun á lifrarstarfsemi), lifrarbólga*, gallteppa
最后更新: 2017-04-26
使用频率: 1
质量:
biogen inc., 250 binney street, cambridge, massachusetts 02142, usa.
biogen inc., 250 binney street, cambridge, massachusetts 02142, bandaríkin.
最后更新: 2017-04-26
使用频率: 1
质量:
name and address of the manufacturer of the biological active substance boehringer ingelheim vetmedica inc.
heiti og heimilisfang framleiðenda líffræðilegra virkra efna boehringer ingelheim vetmedica inc.
最后更新: 2017-04-26
使用频率: 1
质量:
a clinical study was conducted with the quadrivalent measles, mumps, rubella and varicella vaccine manufactured by merck & co., inc., administered with a 2-dose schedule, the doses being given 3 months apart in 1,620 healthy subjects from 9 to 12 months of age at the time of first dose.
gerð var klínísk rannsókn með fjórgilda bóluefninu gegn mislingum, hettusótt, rauðum hundum og hlaupabólu framleiddu af merck & co., inc., bóluefnið var gefið í tveimur skömmtum samkvæmt áætlun með þriggja mánaða millibili hjá 1.620 heilbrigðum einstaklingum á aldrinum 9 til 12 mánaða við gjöf fyrsta skammts.
最后更新: 2017-04-26
使用频率: 1
质量:
警告:包含不可见的HTML格式